INNT
TOTAL INVALIDATION PROCESSED BY THE IB
06/06/2015
Back to search
Official data from USPTO
MYCOGRAB
Did you know this trademark is already registered in United States?
Before investing in name, identity, and promotion, validate collision risk and registration strategy to avoid wasting time and budget.
Active USPTO registrationType: WordOffice: US
Risk and opportunity diagnosis
Executive reading for naming, filing, and monitoring decisions.
USPTO status
Active USPTO registration
Case type
Application and registration
Recorded events
31
Latest update
03/16/2016
Classification
Registered
Trademark type
Word
Nice classes
5
Filing date
09/14/2006
Registration date
06/26/2007
Expiration date
-
Recommended action
Perform a full collision analysis and validate classes before any filing or trademark investment.
Next step
These are the details of the registration process. Even so, constant monitoring is what ensures peace of mind that your main asset remains protected.
Complete case details
Structured fields from the responsible authority and the official record.
Status date
01/31/2014
Last transaction
03/16/2016
Responsible office
United States Patent and Trademark Office
Status code
709
Official register
Principal Register
Drawing code
4
Owner type
03
Owner location
CH
Examiner
HELLMAN, ELI
Law office
M30
Current location
PUBLICATION AND ISSUE SECTION
Holders and representatives
Holders
Novartis AG
Novartis AG
Representatives
Maury M. Tepper, III Tepper & Eyster, PLLC
Technical classification
Nice Classes
Class 5
Vienna Codes
No Vienna codes available.
Goods and services
Class 5
Pharmaceutical preparations for the prevention and treatment of disorders of the nervous systemthe immune systemthe cardio-vascular and metabolic system including diabetesthe respiratory systemthe genitourinary systemmusculo-skeletal and inflammatory disordersfor use in dermatologyoncologyhematologyophthalmologyin tissue and organ transplantation; pharmaceutical preparations for the treatment of gastro-intestinal diseasesfor the prevention and treatment of ocular disorders; pharmaceutical preparations for the treatment of bacteria-based diseases; anti-infectivesantiviralsantibioticsantifungalsvaccinesdiagnostic preparations for medical use
Publications
History of USPTO decisions and trademark events.
31 publications found
XXSS
GENERIC MADRID TRANSACTION SENT TO IB
04/08/2015
XXCR
GENERIC MADRID TRANSACTION CREATED
04/08/2015
INTR
TOTAL INVALIDATION OF REG EXT PROTECTION CREATED
09/30/2014
C71T
CANCELLED SECTION 71
01/31/2014
NREP
NEW REPRESENTATIVE AT IB RECEIVED
04/12/2013
ADCH
CHANGE OF NAME/ADDRESS REC'D FROM IB
02/23/2013
TCCA
TEAS CHANGE OF CORRESPONDENCE RECEIVED
06/28/2009
FINO
FINAL DECISION TRANSACTION PROCESSED BY IB
09/20/2008
FICS
FINAL DISPOSITION NOTICE SENT TO IB
11/09/2007
FIMP
FINAL DISPOSITION PROCESSED
11/09/2007
FICR
FINAL DISPOSITION NOTICE CREATED, TO BE SENT TO IB
11/06/2007
R.PR
REGISTERED-PRINCIPAL REGISTER
06/26/2007
PUBO
PUBLISHED FOR OPPOSITION
04/10/2007
NPUB
NOTICE OF PUBLICATION
03/21/2007
PREV
LAW OFFICE PUBLICATION REVIEW COMPLETED
02/20/2007
ALIE
ASSIGNED TO LIE
02/20/2007
CNSA
APPROVED FOR PUB - PRINCIPAL REGISTER
01/12/2007
XAEC
EXAMINER'S AMENDMENT ENTERED
01/08/2007
GNEA
EXAMINERS AMENDMENT E-MAILED
01/08/2007
CNEA
EXAMINERS AMENDMENT -WRITTEN
01/08/2007
RFNT
REFUSAL PROCESSED BY IB
12/29/2006
ARAA
ATTORNEY/DOM.REP.REVOKED AND/OR APPOINTED
12/20/2006
REAP
TEAS REVOKE/APP/CHANGE ADDR OF ATTY/DOM REP RECEIVED
12/20/2006
RFCS
NON-FINAL ACTION MAILED - REFUSAL SENT TO IB
12/13/2006
RFRR
REFUSAL PROCESSED BY MPU
12/13/2006
RFCR
NON-FINAL ACTION (IB REFUSAL) PREPARED FOR REVIEW
12/08/2006
CNRT
NON-FINAL ACTION WRITTEN
12/07/2006
DOCK
ASSIGNED TO EXAMINER
12/04/2006
NWAP
NEW APPLICATION ENTERED
11/24/2006
REPR
SN ASSIGNED FOR SECT 66A APPL FROM IB
11/23/2006
Continuous trademark protection
Get notified about every new filing that threatens MYCOGRAB or your mark.
Professional 24-month watch service: we monitor USPTO for you and alert you in time to oppose — before conflicts become losses.